Impact of the large-scale deployment of artemether/lumefantrine on the malaria disease burden in Africa: Case studies of South Africa, Zambia and Ethiopia

Malaria Journal

Volumn 8, Issue SUPPL. 1, 2009, Pages

  Barnes, Karen I ^a   Chanda, Pascalina ^b   Ab Barnabas, Gebre ^c  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b MINISTRY OF HEALTH   (Zambia)

^c Tigray Health Bureau   (Ethiopia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ARTICLE; BED NET; COST EFFECTIVENESS ANALYSIS; ENDEMIC DISEASE; ETHIOPIA; GAMETOCYTE; HOSPITAL ADMISSION; HUMAN; MALARIA; MALARIA CONTROL; MALARIA FALCIPARUM; MORBIDITY; MORTALITY; OUTPATIENT; PARASITE TRANSMISSION; PESTICIDE SPRAYING; PRACTICE GUIDELINE; PROSPECTIVE STUDY; SCALE UP; SOUTH AFRICA; VECTOR CONTROL; ZAMBIA; ZOONOSIS; AFRICA; DRUG COMBINATION; REVIEW;

AFRICA; ANTIMALARIALS; ARTEMISININS; DRUG COMBINATIONS; ETHANOLAMINES; FLUORENES; HUMANS; MALARIA;

EID: 70350004832     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-8-S1-S8     Document Type: Article

References (37)

1. World Malaria Day Factsheet 25 April 2009 [http://www.rollbackmalaria. org/worldmalariaday/docs/fact-sheet-RBM.pdf]
2. WHO World Malaria Report 2008. http://who.int/malaria/wmr2008
3. African Malaria Day Fact Sheet (WHO). http://www.rollbackmalaria.org/ docs/AMD/factsheet.htm
4. Key malaria facts. Roll Back Malaria, http://www.rbm.who.int/key-facts. html
5. Efficacy of six doses of artemether-lumefantrine (benflumetol) in multidrug-resistant Plasmodium falciparum malaria. M van Vugt P Wilairatana B Gemperli I Gathmann L Phaipun A Brockman C Luxemburger NJ White F Nosten S Looareesuwan, Am J Trop Med Hyg 1999 60 936 942 10403324
6. Artemether-lumefantrine for the treatment of multi-drug resistant falciparum malaria. M van Vugt S Looareesuwan P Wilairatana R McGready L Villegas I Gathmann R Mull A Brockman NJ White F Nosten, Trans R Soc Trop Med Hyg 2000 94 545 548 10.1016/S0035-9203(00)90082-8 11132386 (Pubitemid 30793838)
7. A clinical and pharmacokinetic trial of six doses of artemether- lumefantrine for multidrug-resistant Plasmodium falciparum malaria in Thailand. G Lefèvre S Looareesuwan S Treeprasertsuk S Krudsood U Silachamroon I Gathmann R Mull R Bakshi, Am J Trop Med Hyg 2001 64 247 256 11463111
8. Treatment of acute uncomplicated falciparum malaria with artemether-lumefantrine in non-immune populations: a safety, efficacy and pharmacokinetic study. C Hatz J Soto HD Nothdurft T Zoller T Weitzel L Loutan F Bricaire F Gay GD Burchard K Andriano G Lefèvre PI De Palacios B Genton, Am J Trop Med Hyg 2008 78 241 247 18256423
9. Efficacy and safety of artemether-lumefantrine (Coartem) tablets (six-dose regimen) in African infants and children with acute, uncomplicated falciparum malaria. C Falade M Makanga Z Premji CE Ortmann M Stockmeyer PI de Palacios, Trans R Soc Trop Med Hyg 2005 99 459 467 10.1016/j.trstmh.2004.09.013 15837358
10. Efficacy and safety of artemether-lumefantrine dispersible tablets compared with crushed commercial tablets in African infants and children with uncomplicated malaria: a randomised, single-blind, multi-centre trial. S Abdulla I Sagara S Borrmann U D'Alessandro R Gonzlez M Hamel B Ogutu A Mårtensson J Lyimo H Maiga P Sasi A Nahum Q Bassat E Juma L Otieno A Björkman HP Beck K Andriano M Cousin G Lefèvre D Ubben Z Premji, Lancet 2008 372 1819 1827 10.1016/S0140-6736(08)61492-0 18926569
11. Coartem® (artemether-lumefantrine) Tablets for the treatment of malaria in patients with acute, uncomplicated infections due to Plasmodium falciparum or mixed infections including P. falciparum. NDA 22-268. M Cousin S Kummerer G Lefèvre AC Marrast D Stein M Weaver, http://www.fda.gov/ohrms/ dockets/ac/08/briefing/2008-4388b1-02-Novartis.pdf
12. Combination therapy for uncomplicated falciparum malaria in Ugandan children: a randomized trial. G Dorsey S Staedke TD Clark D Njama-Meya B Nzarubara C Maiteki-Sebuguzi C Dokomajilar MR Kamya PJ Rosenthal, JAMA 2007 297 2210 2219 10.1001/jama.297.20.2210 17519410
13. Artemether-lumefantrine versus amodiaquine plus sulfadoxine-pyrimethamine for uncomplicated falciparum malaria in Burkina Faso: a randomised non-inferiority trial. I Zongo G Dorsey N Rouamba H Tinto C Dokomajilar RT Guiguemde PJ Rosenthal JB Ouedraogo, Lancet 2007 369 491 498 10.1016/S0140-6736(07)60236-0 17292769
14. WHO Prequalification Programme: Priority Essential Medicines. Access to artemisinin-based antimalarial medicinal products of acceptable quality. http://apps.who.int/prequal/lists/mal-suppliers.pdf
15. Effect of artemether-lumefantrine policy and improved vector control on malaria burden in KwaZulu-Natal, South Africa. KI Barnes DN Durrheim F Little, PLoS Med 2005 2 330 16187798 10.1371/journal.pmed.0020330 (Pubitemid 41735780)
16. Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh: a randomised controlled trial. MM Rahman AM Dondorp NP Day N Lindegardh M Imwong MA Faiz AM Bangali AT Kamal J Karim J Kaewkungwal P Singhasivanon, Trans R Soc Trop Med Hyg 2008 102 861 867 10.1016/j.trstmh.2008.05.022 18606428
17. Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. C Muheki D McIntyre KI Barnes, Trop Med Int Health 2004 9 959 66 10.1111/j.1365-3156.2004.01292.x 15361108
18. Safety and efficacy of lumefantrine-artemether (Coartem) for the treatment of uncomplicated Plasmodium falciparum malaria in Zambian adults. M Mulenga JP Van Geertruyden L Mwananyanda V Chalwe F Moerman R Chilengi C Van Overmeir JC Dujardin U D'Alessandro, Malar J 2006 5 73 16923176 10.1186/1475-2875-5-73 (Pubitemid 44481293)
19. Artemisinin-based combination therapy in Zambia: from policy change to implementation. http://www.rbm.who.int/docs/zambia-act-deploying.pdf
20. National Malaria Control Centre. National Malaria Situation Analysis 2000. http://www.cboh.gov.zm/documents/Copy of Final Malaria SADocument 2000.pdf
21. Evidence of substantial nationwide reduction of malaria cases and deaths due to scale-up of malaria control activities in Zambia, 2001-2008. E Chizema-Kawesha V Mukonka M Mwanza C Kaliki M Phiri J Miller R Komatsu M Aregawi F Masaninga S Kitikiti O Babaniyi M Otten, World Health Organization, Zambia 19-23 January. Impact Evaluation Mission Report
22. Paediatric malaria case-management with artemther-lumefantrine in Zambia: A repeat cross-sectional study. D Zurovac M Ndhlovu N Sipilanyambe P Chanda DH Hamer JL Simon RW Snow, Malar J 2007 6 31 17367518 10.1186/1475-2875-6-31 (Pubitemid 46482315)
23. Integrated vector management: The Zambian experience. E Chanda F Masaninga M Coleman C Sikaala C Katebe M Macdonald KS Baboo J Govere L Manga, Malar J 2008 7 164 18752658 10.1186/1475-2875-7-164
24. Ministry of Health, Health Management Information System 2001-2006, Lusaka, Zambia
25. A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia. P Chanda F Masiye BM Chitah N Sipilanyambe M Hawela P Banda T Okorosobo, Malar J 2007 6 21 17313682 10.1186/1475-2875-6-21 (Pubitemid 46303887)
26. Zambia National Malaria Indicator Survey 2006. Zambia Ministry of Health, Lusaka, Zambia: Ministry of Health 2006 http://nmcc.org.zm.whsites.net/files/ 2006-Zambia-Malaria-Indicator-Survey.pdf
27. Zambia National Malaria Indicator Survey 2008. Zambia Ministry of Health, Lusaka, Zambia: Ministry of Health 2008 http://www.nmcc.org.zm/files/ ZambiaMIS2008Final.pdf
28. Early results of integrated malaria control and implications for the management of fever in under-five children at a peripheral health facility: a case study of Chongwe rural health centre in Zambia. P Chanda B Hamainza S Mulenga V Chalwe C Msiska E Chizema-Kawesha, Malar J 2009 8 49 19292919 10.1186/1475-2875-8-49
29. Changes in inpatient pediatric malaria case load at Macha Hospital after the introduction of artemether/lumefantrine in a rural Zambian community. P Thuma, Symposium 54, 56th ASTMH Annual Meeting, Philadelphia, November 2007
30. Health, a key to prosperity. Success stories in developing countries. http://www.who.int/inf-new/mala.htm
31. Efficacy of sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Ethiopia. D Jima G Tesfaye A Medhin A Kebede D Argaw O Babaniyi, East Afr Med J 2005 82 391 395 16261914 (Pubitemid 41539863)
32. Deployment of Artemether Lumefantrine (AL) at community level and its impact on malaria specific death rate during an epidemic year [abstract]. A Getachew A Desta H Lemma E Fottrell Tigray Malaria Study Group, Am J Trop Med Hyg 2007 77 206
33. WHO, the Global Fund, and medical malpractice in malaria treatment. A Attaran KI Barnes C Curtis U d'Alessandro CI Fanello MR Galinski G Kokwaro S Looareesuwan M Makanga TK Mutabingwa A Talisuna JF Trape WM Watkins, Lancet 2004 363 237 240 10.1016/S0140-6736(03)15330-5 14738799
34. WHO World Malaria Report 2008: Chapter 4 - Interventions to control malaria. http://www.who.int/malaria/wmr2008/MAL2008-Chap4-EN.pdf
35. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. F Nosten M van Vugt R Price C Luxemburger KL Thway A Brockman R McGready F ter Kuile S Looareesuwan NJ White, Lancet 2000 356 297 302 10.1016/S0140-6736(00)02505-8 11071185
36. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. A Bhattarai AS Ali SP Kachur A Mårtensson AK Abbas R Khatib AW Al-Mafazy M Ramsan G Rotllant JF Gerstenmaier F Molteni S Abdulla SM Montgomery A Kaneko A Björkman, PLoS Med 2007 4 309 17988171 10.1371/journal.pmed.0040309 (Pubitemid 350220531)
37. Initial evidence of reduction of malaria cases and deaths in Rwanda and Ethiopia due to rapid scale-up of malaria prevention and treatment. M Otten M Aregawi W Were C Karema A Medin W Bekele D Jima K Gausi R Komatsu E Korenromp D Low-Beer M Grabowsky, Malar J 2009 8 14 19144183 10.1186/1475-2875-8-14